bioRxivMicrobiology
Bimodal distribution of Candida albicans in children with Autism linked with ASD symptoms
K. Nirmalkar, J. Patel, D.-W. Kang, A. Bellinghiere, D. A. Bowes, J. B. Adams, R. Krajmalnik-Brown
Abstract
The gastrointestinal (GI) tract harbors an intricate and remarkably diverse microbial ecosystem that profoundly impacts various aspects of health and pathophysiology. While bacteria overwhelmingly represent most of the GI microbiota, it is imperative to consider the presence and function of fungal constituents (i.e., mycobiota) within the GI ecosystem. The substantial incidence of GI disorders and associated manifestations in children diagnosed with autism spectrum disorder (ASD) suggests a plausible contributory role of the gut mycobiota. Our investigation aimed to elucidate the gut mycobiota in a cohort comprising 38 typically developing children (TD) and 40 children with ASD. Fecal samples were collected from all participants and autism severity and GI symptoms were assessed to unravel the potential implications of mycobiota alterations in the gut. We employed fungal internal transcribed spacer (ITS) gene amplicon sequencing to analyze the fungal composition and investigate their relationship with GI and autism symptoms. Among gut mycobiota, Saccharomyces cerevisiae was significantly lower (relative abundance) in ASD compared to TD children. Total Candida and C. albicans demonstrated a bimodal distribution among children with ASD. Children with ASD with elevated Autism Treatment Evaluation Checklist (ATEC) scores (a more severe diagnosis) displayed an increased abundance of C. albicans and a decreased abundance of S. cerevisiae. A significant positive correlation was observed between ATEC scores and GI symptoms and between ATEC scores and C. albicans. Our findings propose that a deficit of beneficial fungi, specifically S. cerevisiae, and an overgrowth of C. albicans may worsen autism severity in children with ASD. Future work employing more advanced techniques (i.e., shotgun metagenomics) is encouraged to advance understanding of the functional role of fungi/yeast, and their interplay between GI symptoms and autism severity in children with ASD.
- organism: human
- assay: metagenomics
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- New Evidence of Altered Gut Microbiota in Autism Spectrum Disorders through Metagenomic Analysis
Peiqi Xing, Zhaohua Li, … Yīmíng Bào·bioRxiv·Sep 11, 2025
- Digestive Dimensions of Autism: A Multiscale Exploration of Gut-Brain Interactions
Raz Robas, Utkarsh Tripathi, … Shani Stern·bioRxiv·Jul 29, 2025
- Bacteroides is increased in an autism cohort and induces autism-relevant behavioral changes in mice in a sex-dependent manner
Julie Carmel, Nasreen Ghanayem, … Evan Elliott·bioRxiv·Oct 5, 2023
- Crowdsourced study of children with autism and their typically developing siblings identifies differences in taxonomic and predicted function for stool-associated microbes using exact sequence variant analysis.
Maude M David, Christine Tataru, … Dennis P. Wall·bioRxiv·May 25, 2018
- Multi-Omic Dissection of Autism Reveals Dominant Effects of Family, Sex, and Host-Microbe Metabolic Interactions
Ashley G. Bell, Kiana West, … Jeremy Kirk Nicholson·bioRxiv·Jul 22, 2026
- A quasi-paired cohort strategy reveals the impaired detoxifying function of microbes in the gut of autistic children
M. Zhang, Y. Chu, … J. Wang·Science AdvancesPeer-reviewed·Oct 23, 2020